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Summary
Objective: The Lysholm Knee Scale is an 8-item questionnaire originally designed as an outcome measure for ligament reconstruction but is
commonly used as a measure for knee chondral damage. This study tests the scale’s internal construct validity using the Rasch model,
a measurement model which sets strict standards for the quality of measurement derived from the scale. The study also investigates the level
of agreement between scores from patients and physiotherapists; and reviews the present weighting system.
Design: One hundred and ﬁfty-seven patients with knee chondral damage awaiting surgery completed the Lysholm as part of a multicentre
clinical trial based in 16 UK and two Norwegian hospitals. The patients were assessed by a physiotherapist who independently completed the
Lysholm on the same day.
Results: Fit to the Rasch model was achieved [mean item ﬁt 0.26, standard deviation (SD) 1.01] after removal of one item (Swelling). With no
differential item functioning (DIF) by rater, the intraclass correlation coefﬁcient was 0.9 [95% conﬁdence interval (CI): 0.86e0.93] and
a BlandeAltman plot showed no consistent difference in rating.
Conclusions: The Lysholm Knee Scale satisﬁes Rasch model expectations after removal of the swelling item. Generally there is a high degree
of agreement between the patient and professional ratings. By removing the swelling item and using unweighted scores, a modiﬁed version of
the Lysholm Knee Scale is recommended as an outcome measure for knee chondral damage.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction joints
5. Patients selected for ACI represent a relatively smallIn recent years there has been considerable emphasis on
the use of patient-reported outcomes to evaluate health
care interventions1e3. Taking the form of self-completed
questionnaires, this approach has the obvious practical
advantage of quick and easy completion in any setting with-
out the need for clinical staff to be in attendance. Therefore,
when looking to evaluate any intervention, it is usual to
choose one or more patient-reported outcome scales rele-
vant for the intervention.
This was the case when setting up a randomised con-
trolled trial of autologous chondrocyte transplantation / im-
plantation vs existing treatments (ACTIVE). The ACTIVE
trial compares autologous chondrocyte implantation (ACI)
with the surgeon’s best alternative standard treatment (for
example microfracture, debridement, mosaicplasty)4. Over
the last decade ACI has emerged as a tissue engineering
technique with the potential to restore articular cartilage in*Address correspondence and reprint requests to: Dr Heather
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53group of patients who typically have at least one isolated
chondral lesion. This will usually be located on the femoral
condyle but may also be on the trochlea or patella. To qual-
ify for the trial, the lesion will have remained symptomatic
following previous arthroscopic treatment such as debride-
ment or microfracture6,7. The prevalence of symptomatic
chondral defects in the knee is unclear. However, a retro-
spective review of over 31,000 arthroscopies in the United
States found chondral lesions in 63% of patients8.
ACI patients are relatively young (average age in the
ACTIVE trial is 37 years) and many aim to return to
a high level of activity or sports participation. It was there-
fore considered important to select outcome tools that
were broad enough to measure high levels of activity. In
the ACTIVE trial patients complete the Lysholm Knee
Scale9, the Cincinnati Sports Activity rating10 and the Inter-
national Knee Documentation Committee (IKDC) Subjec-
tive Knee Form11. The latter two questionnaires are
speciﬁcally designed to measure sports activity.
The choice of outcome scale is inﬂuenced by the quality
of its psychometric properties. Modern psychometric
methods are increasingly applied to test whether the
patient-reported outcome tools satisfy current standards of
measurement, in addition to the traditional properties of
reliability and validity12e15. The most widely used approach
54 H. J. Smith et al.: Validity of the Lysholm Knee Scaleis that of the Rasch measurement model, where it is possi-
ble to test whether the scale is measuring a single construct
(unidimensionality); whether the items are free of bias, and
whether the response categories are working as
intended16,17. Computer software enables these tests to
be carried out relatively easily, and for measures that are
shown to satisfy Rasch model expectations, the ordinal
ratings are transformed into linear scores suitable for para-
metric statistical analysis.
This approach has only been applied to a limited number
of outcome measures when used for assessing orthopaedic
interventions. For example, Rasch analysis of the Oxford
Hip Score to assess total hip replacement gave greater dis-
crimination across different clinical groups relative to con-
ventionally summed scores15; and Rasch analysis of the
Western Ontario McMaster (WOMAC) Osteoarthritis Index
identiﬁed a modiﬁed version which ﬁtted the model when
assessing total hip and knee replacements18. The Rasch
model has not previously been applied to the Lysholm
Knee Scale and so the current study provided the opportu-
nity to test the scale against the most rigorous modern stan-
dards for measurement and, crucially, to show that an
interval scale transformation could be obtained to facilitate
the valid calculation of change scores. In addition, the study
allowed for an examination of the levels of agreement
between scores collected from patients and independently
by physiotherapists; and to review the appropriateness of
the weighting of items for use after articular cartilage injury.Patients and methodsPARTICIPANTSPatients with isolated symptomatic cartilage defects on the femoral con-
dyle or trochlea were recruited into a multicentre randomised controlled trial
between December 2004 and July 2007. Patients were recruited from 18 dif-
ferent hospitals (16 in the UK, two in Norway). The trial was approved by the
North Staffordshire Research Ethics Committee (ref. 04/Q2604/10). All
patients had had at least one previous procedure on the same defect which
had failed to relieve symptoms. Patients with generalised osteoarthritis or
knee instability were excluded from the trial.THE LYSHOLM KNEE SCALEThe Lysholm Knee Scale is an 8-item questionnaire scored on a 0e100
weighted scale measuring pain (25 points), instability (25 points), locking
(15 points), swelling (10 points), limp (5 points), stair-climbing (10 points),
squatting (5 points) and use of support (5 points). The scale was originally
designed to assess ligament injuries of the knee9 but it is commonly used
as a self-complete measure in surgical studies involving patients with chon-
dral damage6,19,20. On a large sample of patients with various chondral dis-
orders (n¼ 1657) the scale was reported as demonstrating overall
acceptable psychometric properties using traditional tests of reliability
(overall intraclass correlation coefﬁcient 0.91) internal consistency (Cron-
bach alpha 0.65) and construct validity, but with some items indicating
a lack of content validity by having a signiﬁcant ﬂoor or ceiling effect21.PROCEDUREThe Lysholm Knee Scale was self-completed by all patients within 3
months prior to randomisation and surgery. On the day patients completed
the form, an independent assessor (a physiotherapist based at each hospi-
tal) carried out a semi-structured interview, a physical examination and func-
tional tests with the patient. Based on information and observations from this
assessment, and without looking at the patient’s own scores, the assessor
also completed the Lysholm Knee Scale. In Norway, the Lysholm Knee
Scale had already been translated into Norwegian for a previous study6.RASCH ANALYSISThe Rasch model estimates the item difﬁculty and the patient ability level
on a common linear scale from the responses given to each item. The
response patterns to the items are tested against what is expected: that
the probability of a given respondent afﬁrming an item (or a category within
an item) is a logistic function of the relative distance between the itemlocation and the respondent location on a linear scale. A variety of ﬁt statis-
tics determine whether this is the case22. Unlike other forms of statistical
modelling where the model is adapted to ﬁt the data (e.g., regression analy-
sis) Rasch analysis deﬁnes measurement and the data must ﬁt the model ex-
pectations if linear measurement is to be achieved23.
Data from both patients and physiotherapists were pooled and ﬁtted to the
Rasch model using the RUMM2020 software24. To evaluate whether or not
the scale meets model expectations three overall ﬁt statistics are used. Two
are itemeperson interaction statistics transformed to approximate a z score,
representing a standardised normal distribution. Therefore, if the items and
persons ﬁt the model we would expect a mean of approximately zero and
a standard deviation (SD) of 1. A third ﬁt statistic is the itemetrait interaction
reported as a chi-square: a signiﬁcant chi-square indicates that the hierarchi-
cal ordering of items varies across the construct, thus compromising the
requirement of invariance. Further individual item ﬁt and person ﬁt statistics
are available as residuals and as a chi-square. Residuals between 2.5
indicate adequate ﬁt to the model, without over- or under-discrimination.
Responses to categories on individual items should work in the correct
order so that the thresholds between successive response categories corre-
spond with increasing levels of ability/function. Categories are often disor-
dered if there are too many categories, or if respondents are confused by
the wording and cannot distinguish consistently between response labels.
This is tested in RUMM graphically and where necessary, categories are col-
lapsed to achieve ordered thresholds. During the iterative process of Rasch
analysis all the above statistics are checked and rechecked once categories
are correctly ordered. At this stage in the analysis it may also be necessary
to remove any misﬁtting items, and sometimes, misﬁtting persons are
removed to achieve overall ﬁt to the model.
Items should also be checked for differential item functioning (DIF) and
this is possible in RUMM both statistically by analysis of variance, and graph-
ically25. Uniform DIF may be present if, for example, at the same level of abil-
ity, men consistently rate themselves higher than women on a given item. In
this case the item would be calibrated separately (split) for males and
females. If an item has non-uniform DIF, for example, some men rate them-
selves signiﬁcantly higher at a low level of ability, while other men at a higher
ability rate themselves signiﬁcantly lower than women, it may be necessary
to remove the item from the scale. In the present study it was important to
test for DIF by rater (patient vs assessor) as well as for DIF by gender.
The Rasch model is a unidimensional measurement model, thus the
assumption is that the items summated together form a unidimensional
scale. Rasch programs usually provide a principal components analysis
(PCA) of the residuals to help interpret unidimensionality. A PCA test takes
the patterning of items in the residuals and uses these patterns to deﬁne two
subsets of items (i.e., the positively and negatively correlated items)26. These
two sets of items are then used to make separate person estimates and,
using an independent t test for the difference in these estimates for each per-
son, the number of such tests outside the range 1.96 should not exceed
5%. A conﬁdence interval (CI) for a binomial test of proportions is calculated
for the observed number of signiﬁcant tests, and this value should overlap
the 5% expected value for the scale to be unidimensional.AGREEMENT BETWEEN RATERSAgreement between raters (patients vs physiotherapists) was examined
statistically within the Rasch analysis as DIF by rater; by using a two-way
mixed effect intraclass correlation coefﬁcient (3,1) and graphically with
a BlandeAltman plot where the differences between raters are plotted
against the averages of the two different types of rater.
Results
A total of 157 patients with isolated symptomatic cartilage
defects on the femoral condyle (145) or trochlea (12) were
recruited. Patients were aged from 17 to 59 years
(mean¼ 37, SD¼ 9.03) and there were 107 males (67%).FIT TO THE RASCH MODELInitially the data from the Lysholm Knee Scale showed
discordance with Rasch model expectations (misﬁt) as indi-
cated by a signiﬁcant itemetrait interaction total chi-square
of 105.15 (df¼ 40) with P¼<0.00001 and a residual
mean value for items of 0.35 with a SD of 1.63, far higher
than expected by the model. The residual mean value for
persons was 0.28 (SD¼ 0.95) indicating no serious misﬁt
among the respondents. Four items (pain, instability, locking
and squatting) had disordered category thresholds which
meant that their categories did not work in the intended
Fig. 1. (a) Category probability curves for the squatting item showing disordered thresholds. (b) Category probability curves for the squatting
item showing ordered thresholds after collapsing categories 1 and 2.
Table I
Fit of the Lysholm items after recoding items 1, 2, 3 & and 7 and
removing item 4 (Swelling)
Item Location Standard
error
Fit
residual
df Chi-
square
df Probability
1 Pain 2.505 0.077 0.93 271 6.358 5 0.273
2 Instability 0.506 0.09 0.169 271 6.334 5 0.275
3 Locking 1.216 0.098 0.904 271 3.233 5 0.664
5 Limp 0.405 0.113 0.799 271 3.856 5 0.570
6 Stairs 1.161 0.116 1.614 271 12.031 5 0.034
7 Squatting 1.637 0.124 1.194 271 4.999 5 0.416
8 Support 2.676 0.177 0.408 271 6.628 5 0.250
55Osteoarthritis and Cartilage Vol. 17, No. 1order. For example (see Fig. 1) with the squatting item, the
second category (labelled 1) (my squatting is slightly im-
paired because of my knee) and the third category (labelled
2) (I can’t squat beyond 90) were overlapping and not con-
tributing data to represent different levels of functioning. By
grouping such categories (often referred to as collapsing
disordered categories) so that the data from both categories
were combined into one single category, it was possible to
achieve ordered thresholds on all items.
After recoding the four items to achieve ordered thresholds,
the overall ﬁt of the data to the model was improved but the
summary itemetrait interaction ﬁt statistic still showed signiﬁ-
cant misﬁt (0.0005) and the summary SD remained high
(1.75). On inspection of the individual items, the ‘swelling’
item showed a ﬁt residual of 4.22, far above the 2.5 upper limit
of acceptability for this ﬁt statistic. This means that the item
failed to discriminate across the underlying trait of knee im-
pairment. Removal of this item resulted in an improvement
of the mean item ﬁt to 0.26 (SD 1.01), with all remaining
itemswell within theexpected residual rangeof2.5 (Table I).
Patients were least likely to be pain free, and most likely
not to use weight-bearing support as shown by the item
locations in Table I. The items instability and limping were
both located close to zero logits, the mean level of item dif-
ﬁculty along the scale. The mean person score was close to
zero (0.69) suggesting the scale was reasonably well tar-
geted to the group of patients who were only slightly better
than the average of the scale items. Figure 2 shows thedistributions of persons (top half of the graph) and item
thresholds (bottom half of the graph) for the total linearised
score. There was no ﬂoor effect in this patient group and not
surprisingly, since all patients were symptomatic and requir-
ing knee surgery, there was no ceiling effect. Internal con-
sistency reliability remained adequate for group use with
a person separation index (PSI) of 0.73.
Possible gender and rater differences were explored by
analysis of DIF. None of the items showed uniform DIF
and only one item (stair-climbing) showed some degree of
non-uniform DIF by gender (P¼ 0.005) although this was
not below the adjusted alpha value.
Finally, strict unidimensionality of the 7-item version was
observed through a PCA of the residuals [t tests 7.8% (CI:
5e10%)].
Fig. 2. Personeitem distribution graph for the 7-item Lysholm Knee Scale.
56 H. J. Smith et al.: Validity of the Lysholm Knee ScaleAGREEMENT BETWEEN RATERSAfter satisfying the Rasch model expectations, and ﬁnd-
ing no DIF by rater at the item level, the two-way mixed
effect intraclass correlation coefﬁcient was found to be 0.9
(95% CI: 0.86e0.93) and a BlandeAltman plot showed no
consistent difference in ratings (Fig. 3). Therefore, there
was generally a high level of agreement between patients
and their physiotherapist.Discussion
Identifying high quality patient-reported outcomes to eval-
uate an intervention is a key component of that evalua-
tion27,28. In this paper we have shown that the Lysholm
Knee Scale, in an adjusted form of seven items, satisﬁes
the most rigorous measurement standards29 when used to
assess patients with articular cartilage defects in the knee
suitable for cell grafting techniques or standard treatments
such as microfracture. In doing so a linear transformation of
the person estimate is achieved for use in parametric analy-
sis, such as the Bland and Altman Plot shown below.
Some of the categories of the items in the scale had to be
collapsed to ensure a proper ordering of the underlying trait.Bland–Altman plot
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Fig. 3. The BlandeAltman plot showing an even distribution of
scores around the mean difference.This may occur because patients have difﬁculty discriminat-
ing across the responses. For the time being, the original cat-
egories should not be changed, until such time that repeated
studies show continuing problems with these categories.
Note how the hierarchical ordering of the items in Table I,
as demonstrated by the location value, does not correspond
to the weighting of items. While pain and instability both
score 25 points in the original, squatting only scores 5
points, yet squatting is located between pain and instability
on the continuum of impact. This suggests that the original
weighting is incorrect and, given the raw score is a sufﬁcient
statistic for a person estimate in the Rasch model, a simple
summation of the seven items will sufﬁce to give a good
person estimate. If the same range as the original (i.e.,
0e100) is required, multiply the raw score by 4.167 (see
Appendix I for full details of the adjusted scale).
Occasionally, scales that were originally developed for
use by clinicians have also been used as patient-reported
scales. This can allow a comparison of scores between
the two types of administration and in this case we have
shown that there is generally a high level of agreement
between the physiotherapist- and patient-completed scales.
In practical terms this means that the different admini-
strative modes are interchangeable. For example, the
instrument could be administered in clinic by a physiothera-
pist, but by postal self-completion at 3 months.
The high level of agreement between raters’ scores may
not be surprising, given that physiotherapists could obtain
answers to some of the questions by simply asking the
patients: for example, ‘‘has your knee locked’’ or ‘‘do you
have a catching sensation’’. However, the physiotherapists
rated patients as objectively as possible using a combina-
tion of interview questions, physical examination of the
knee, and functional exercises such as walking on a tread-
mill, and squatting. It is possible that this agreement
between raters’ scores seen pre-operatively may change
over time, therefore a further analysis of agreement levels
is planned for the 1 year follow-up scores. Further analysis
of scores collected post-operatively would also be worth-
while to investigate whether the Lysholm Knee Scale is
valid for targetting patients as they progress to better levels
of functioning.
57Osteoarthritis and Cartilage Vol. 17, No. 1For patients returning to competitive sports, items from
the Cincinnati Sports Activity rating and the IKDC could
be used alongside the adapted Lyhsolm Knee Scale to pro-
vide a wider ranging scale. If these scales are found to be
measuring the same construct (albeit at differing levels of
ability) and the combined item set were found to ﬁt Rasch
model expectations, then it would be possible to construct
an ‘item bank’ of functioning that would allow for continuity
of measurement from pre-operative state through to the
return to sporting activity30.
There are some limitations to this work. The Rasch model
is a formal test of the internal construct validity of a scale,
and cannot say anything about its content (whether the
scale measures what is relevant to the intended construct)
or other forms of validity. It therefore supplements existing
psychometric tests of reliability and validity (although tech-
nically it should come before these tests as they will be
compromised if the scale is not internally valid). The sampleAppendix I. Lysholm Knee Scale: revised version for c
Pain
I have no pain in my knee
I have intermittent pain in my knee during severe exertion
I have marked pain in my knee during severe exertion
I have marked pain in my knee on or after walking more than 2 km
I have marked pain in my knee on or after walking less than 2 km
My knee is in constant pain
Instability
My knee never gives way
My knee rarely gives way during athletics or other severe exertion
My knee frequently gives way during athletics or other severe exertion
My knee occasionally gives way during daily activities
My knee often gives way during daily activities
My knee gives way with every step I take
Locking
I experience no locking or catching sensation
I do experience a catching sensation but not a locking sensation
I occasionally have a locking sensation
I frequently have a locking sensation
I have a locked knee now
Swelling
My knee does not swell
My knee swells on severe exertion
My knee swells on ordinary exertion
My knee is constantly swollen
Limp
I have no limp
I have a slight limp or periodical limp
I have a severe and constant limp
Stair-climbing
I have no problems climbing stairs because of my knee
My stair-climbing is slightly impaired because of my knee
I climb stairs one foot at a time because of my knee
Stair-climbing is impossible because of my knee
Squatting
I have no problems squatting
My squatting is slightly impaired because of my knee
I can’t squat beyond 90(
Squatting is impossible because of my knee
Support
I am not using any kind of support
I am using a stick or crutch
Weight-bearing is impossible for me due to my knee(s)
*The recommended scores range from 0 to 24. To convert the scale fsize, while adequate for the task in this paper, is neverthe-
less small for making deﬁnitive statements about collapsing
of category responses, and this sort of ﬁnding will need to
be repeated in other studies before recommendations are
made about a formal revision of the number of categories
used. For this reason, we have left the category structure
in its original form, albeit with different scores for each level.
In conclusion, the Lysholm Knee Scale, in a revised 7-
item form, offers a robust unidimensional scale for evaluat-
ing patients undergoing treatment for articular cartilage dam-
age. It satisﬁes the strictest modern psychometric standards
for measurement, is free of bias for gender, and can be rated
by physiotherapists, or self-completed by patients.Conﬂict of interest
The authors have no conﬂict of interest.hondral injuries
Original score Recommended score*
25 5
20 4
15 3
10 2
5 1
0 0
25 5
20 4
15 3
10 2
5 1
0 0
15 4
10 3
6 2
2 1
0 0
10 Remove item
6
2
0
5 2
3 1
0 0
10 3
6 2
2 1
0 0
5 3
4 2
2 1
0 0
5 2
2 1
0 0
rom 0e24 to 0e100 multiply the total score by 4.167.
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